Drug profile · INN
isavuconazonium sulfate
CRESEMBA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
isavuconazonium sulfate (CRESEMBA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN isavuconazonium sulfate
Brand CRESEMBA
Route ORAL
Formulation POWDER
Frequently asked questions
What is isavuconazonium sulfate?
isavuconazonium sulfate (CRESEMBA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for isavuconazonium sulfate?
CRESEMBA is a marketed brand name for isavuconazonium sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of isavuconazonium sulfate?
isavuconazonium sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.